[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:escherichia-coli-infection":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":24,"states":25},"Escherichia coli Infection",2,1,[8,16],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06938867","Phase 1b\u002F2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:19:21.761002Z","2026-05-05T02:43:28.967561Z",{"nct_id":17,"title":18,"phases":19,"status":21,"updated_at":22,"content_modified":23},"NCT07318584","Cefotetan Therapy for Escherichia Coli Infections",[20],"Phase 2","NOT_YET_RECRUITING","2026-08-26T02:16:06.684983Z","2026-05-05T02:43:27.485933Z",[],[]]